Importance of Standard Treatment in Prognosis of Patients with Ovarian Cancer and Associated Cerebral Infarction
Open Access
- 1 February 2020
- journal article
- research article
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 15, 151-157
Abstract
Objective: Data on the treatment of patients with ovarian cancer (OC) and associated cerebral infarction (CI) are extremely limited. The objectives were to investigate the risk factors for prognosis in patients with OC and associated CI. Methods: We retrospectively reviewed the electronic medical records of patients with OC from January 2013 to November 2018 in Peking Union Medical Hospital. Results: In total, 2632 inpatients were diagnosed with malignant ovarian cancer in our institution, and 30 patients (1.1%) were diagnosed with OC-associated CI. The median age was 60 years (range, 37– 83). The standard treatment, according to National Comprehensive Cancer Network (NCCN) guidelines, was administered to 19 patients. The median follow-up time was 19.5 months (range, 1– 59 months). In total, 17 patients experienced tumor progression, and 16 of them died. In univariate analysis, overall survival was significantly associated with the D-dimer level (P=0.017), FIGO stage (P=0.014), complete cytoreduction (P< 0.000) and standard treatment (P< 0.000). In multivariate analysis, the standard treatment remained an independent protective factor for death (hazard ratio=0.061, 95% confidence interval=0.007– 0.537, P=0.012). Conclusion: Although the prognosis of patients with OC and associated CI was poor, those who underwent the standard treatment still benefited.Keywords
This publication has 19 references indexed in Scilit:
- Changes in Serial D-Dimer Levels Predict the Prognoses of Trousseau's Syndrome PatientsFrontiers in Neurology, 2018
- Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerHaematologica, 2018
- Cancer-associated ischemic stroke: A retrospective multicentre cohort studyThrombosis Research, 2018
- Cancer statistics, 2018CA: A Cancer Journal for Clinicians, 2018
- CLINICAL FEATURES OF CANCER ASSOCIATED ISCHEMIC STROKEArchives of Neuropsychiatry, 2018
- Risk of Arterial Thromboembolism in Patients With CancerJACC, 2017
- Global Burden of ThrombosisCirculation Research, 2016
- Cerebral infarction in advanced non-small cell lung cancer: a case control studyBMC Cancer, 2016
- Poor short-term outcome in patients with ischaemic stroke and active cancerJournal of Neurology, 2015
- Incident Cancer in a Cohort of 3,247 Cancer Diagnosis Free Ischemic Stroke PatientsCerebrovascular Diseases, 2015